/ /

Laird Harrison
How to optimally treat rhegmatogenous retinal detachment
Surgeons may safely delay operating on rhegmatogenous retinal detachment (RRD) for a few days to accommodate their schedules, a new study suggested.
Neuroprotective treatment promising for macular telangiectasia
The class of molecules called “neurotrophic factors” has been demonstrated to reduce the rate of photoreceptor cell loss during retinal regeneration.
Expert tips for surgically managing corneal perforations
Expert tips for surgically managing corneal perforations
One of the most memorable patients ever to walk into the office of Sonal Tuli, MD, had a fishhook protruding from his eye, which he held open with his fingers. Dr. Tuli offers some pointers based on experience from cases like these.
How manual cataract surgery rivals phaco for dry eye changes
A study showed manual small incision cataract surgery does not affect tear film stability or tear secretion differently than phacoemulsification does, while it also does not make patients' eyes more dry, either.
Endothelial keratoplasty on the rise in northwestern Italy
Endothelial keratoplasty has become increasingly common in northwestern Italy, paralleling a rise in the demand for corneal surgery, researchers said.
New algorithm accurately estimates corneal power after LASIK
Clinicians can accurately estimate the central corneal power in corneas that have undergone myopic laser refractive surgery using an adjusted keratometric index, researchers said.
Pre-existing ruptured posterior capsule presents unique challenges
Surgeons are urged to take a more cautious approach to cataract surgery when a new, pre-existing rupture of the posterior capsule surfaces.
Novel device reliably measures iridocorneal angles
Scheimpflug photography using a novel device (Sirius, Costruzione Strumenti Oftalmici) provides consistent measurements of the iridocorneal angle at different meridians in healthy eyes and could be used to detect occludable angles.
DME trials show advantage to early aflibercept treatment
DME trials show advantage to early aflibercept treatment
Patients treated early with aflibercept (Eylea, Regeneron Pharmaceuticals) for diabetic macular edema (DME) gain more visual acuity than those treated later in the course of the disease.
Smartphones hold implications for retinal screening, beyond
The advent of smartphone devices and applications is transforming the practice of ophthalmology, especially in regard to ophthalmic diagnosis and monitoring.


View Results